Literature DB >> 1803173

Cancer risks after medical radiation.

P F Hall1.   

Abstract

Radiation-induced tumors cannot be distinguished from tumors in general by means other than a statistical excess. Epidemiological studies are the only means by which answers can be given as regards the carcinogenic effect of ionizing radiation. Age at exposure is perhaps the most important host factor influencing cancer risk and it is generally believed that cancer risk decreases with increasing age at exposure. For most cancers the temporal pattern follows the natural incidence, i.e. the cancers do not occur before ages normally associated with increased incidence. The induction period for solid tumors is at least 10 years while the corresponding figure for leukemia is 2 years. The breast, thyroid, lung and bone marrow seem to be the most radiosensitive tissues, while the risk of chronic lymphatic leukemia and possibly Hodgkin's disease and prostatic cancer does not seem to increase after exposure to ionizing radiation.

Entities:  

Mesh:

Year:  1991        PMID: 1803173     DOI: 10.1007/BF02987171

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  14 in total

1.  Cancer risk in population examined with diagnostic doses of 131I.

Authors:  L E Holm; K E Wiklund; G E Lundell; N A Bergman; G Bjelkengren; U B Ericsson; E S Cederquist; M E Lidberg; R S Lindberg; H V Wicklund
Journal:  J Natl Cancer Inst       Date:  1989-02-15       Impact factor: 13.506

2.  Estimated radiation doses to different organs among patients treated for ankylosing spondylitis with a single course of X rays.

Authors:  C A Lewis; P G Smith; I M Stratton; S C Darby; R Doll
Journal:  Br J Radiol       Date:  1988-03       Impact factor: 3.039

3.  Mortality after radiotherapy for ringworm of the scalp.

Authors:  E Ron; B Modan; J D Boice
Journal:  Am J Epidemiol       Date:  1988-04       Impact factor: 4.897

4.  Radiation dose and second cancer risk in patients treated for cancer of the cervix.

Authors:  J D Boice; G Engholm; R A Kleinerman; M Blettner; M Stovall; H Lisco; W C Moloney; D F Austin; A Bosch; D L Cookfair; E T Krementz; H B Latourette; J A Merrill; L J Peters; M D Schulz; H H Storm; E Bjorkholm; F Pettersson; C M Janine Bell; M P Coleman; P Fraser; F E Neal; P Prior; N W Choi; T G Hislop; M Koch; N Kreiger; D Robb; D Robson; D H Thomson; H Lochmuller; D von Fournier; R Frischkorn; K E Kjørstad; A Rimpela; M H Pejovic; V P Kirn; H Stankusova; F Berrino; K Sigurdsson; G B Hutchison; B MacMahon
Journal:  Radiat Res       Date:  1988-10       Impact factor: 2.841

5.  A parallel analysis of cancer mortality among atomic bomb survivors and patients with ankylosing spondylitis given X-ray therapy.

Authors:  S C Darby; E Nakashima; H Kato
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

6.  Thyroid tumors following thymus irradiation.

Authors:  R E Shore; E Woodard; N Hildreth; P Dvoretsky; L Hempelmann; B Pasternack
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

7.  Radiation carcinogenesis: time-dose relationships.

Authors:  R L Ullrich; M C Jernigan; L C Satterfield; N D Bowles
Journal:  Radiat Res       Date:  1987-07       Impact factor: 2.841

8.  Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients.

Authors:  F G Davis; J D Boice; Z Hrubec; R R Monson
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

9.  Risk of extrathyroid tumors following radiation treatment in infancy for thymic enlargement.

Authors:  N G Hildreth; R E Shore; L H Hempelmann; M Rosenstein
Journal:  Radiat Res       Date:  1985-06       Impact factor: 2.841

10.  Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.

Authors:  S C Darby; R Doll; S K Gill; P G Smith
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

View more
  1 in total

1.  [Radiotherapy of osteoarthritis. Indication, technique and clinical results].

Authors:  R Ruppert; M H Seegenschmiedt; R Sauer
Journal:  Orthopade       Date:  2004-01       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.